97 related articles for article (PubMed ID: 21546779)
1. Epidemiology of Charcot-Marie-Tooth disease in the population of Belgrade, Serbia.
Mladenovic J; Milic Rasic V; Keckarevic Markovic M; Romac S; Todorovic S; Rakocevic Stojanovic V; Kisic Tepavcevic D; Hofman A; Pekmezovic T
Neuroepidemiology; 2011; 36(3):177-82. PubMed ID: 21546779
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of symptomatic Charcot-Marie-Tooth disease in Iceland: a study of a well-defined population.
Gudmundsson B; Olafsson E; Jakobsson F; Lúthvígsson P
Neuroepidemiology; 2010; 34(1):13-7. PubMed ID: 19893324
[TBL] [Abstract][Full Text] [Related]
3. Epidemiologic Study of Charcot-Marie-Tooth Disease: A Systematic Review.
Barreto LC; Oliveira FS; Nunes PS; de França Costa IM; Garcez CA; Goes GM; Neves EL; de Souza Siqueira Quintans J; de Souza Araújo AA
Neuroepidemiology; 2016; 46(3):157-65. PubMed ID: 26849231
[TBL] [Abstract][Full Text] [Related]
4. Molecular diagnosis and clinical onset of Charcot-Marie-Tooth disease in Japan.
Abe A; Numakura C; Kijima K; Hayashi M; Hashimoto T; Hayasaka K
J Hum Genet; 2011 May; 56(5):364-8. PubMed ID: 21326314
[TBL] [Abstract][Full Text] [Related]
5. Epidemiological study of adult-onset myasthenia gravis in the area of Belgrade (Serbia) in the period 1979-2008.
Lavrnic D; Basta I; Rakocevic-Stojanovic V; Stevic Z; Peric S; Nikolic A; Marjanovic I; Pekmezovic T
Neuroepidemiology; 2013; 40(3):190-4. PubMed ID: 23363926
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of myotonic dystrophy type 1 (Steinert disease) in Belgrade (Serbia).
Mladenovic J; Pekmezovic T; Todorovic S; Rakocevic-Stojanovic V; Savic D; Romac S; Apostolski S
Clin Neurol Neurosurg; 2006 Dec; 108(8):757-60. PubMed ID: 16713671
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of multiple sclerosis in the Serbian district Sumadija.
Toncev G; Miletic Drakulic S; Knezevic Z; Boskovic Matic T; Gavrilovic A; Toncev S; Drulovic J; Pekmezovic T
Neuroepidemiology; 2011; 37(2):102-6. PubMed ID: 21921643
[TBL] [Abstract][Full Text] [Related]
8. Pain assessment in Charcot-Marie-Tooth (CMT) disease.
Ribiere C; Bernardin M; Sacconi S; Delmont E; Fournier-Mehouas M; Rauscent H; Benchortane M; Staccini P; Lantéri-Minet M; Desnuelle C
Ann Phys Rehabil Med; 2012 Apr; 55(3):160-73. PubMed ID: 22475878
[TBL] [Abstract][Full Text] [Related]
9. Disease course of Charcot-Marie-Tooth disease type 2: a 5-year follow-up study.
Teunissen LL; Notermans NC; Franssen H; Van Engelen BG; Baas F; Wokke JH
Arch Neurol; 2003 Jun; 60(6):823-8. PubMed ID: 12810486
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, Mortality, and Cause of Death in Charcot-Marie-Tooth Disease in Korea: A Nationwide, Population-Based Study.
Park HJ; Choi YC; Oh JW; Yi SW
Neuroepidemiology; 2020; 54(4):313-319. PubMed ID: 31995800
[TBL] [Abstract][Full Text] [Related]
11. Lower limb manual muscle testing in the early stages of Charcot-Marie-Tooth disease type 1A.
Vinci P; Serrao M; Pierelli F; Sandrini G; Santilli V
Funct Neurol; 2006; 21(3):159-63. PubMed ID: 17049135
[TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of GJB1, MPZ, PMP22, EGR2, and LITAF/SIMPLE in Serbian Charcot-Marie-Tooth patients.
Keckarevic-Markovic M; Milic-Rasic V; Mladenovic J; Dackovic J; Kecmanovic M; Keckarevic D; Savic-Pavicevic D; Romac S
J Peripher Nerv Syst; 2009 Jun; 14(2):125-36. PubMed ID: 19691535
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Charcot-Marie-Tooth disease across the lifespan: a population-based epidemiological study.
Theadom A; Roxburgh R; MacAulay E; O'Grady G; Burns J; Parmar P; Jones K; Rodrigues M;
BMJ Open; 2019 Jun; 9(6):e029240. PubMed ID: 31203252
[TBL] [Abstract][Full Text] [Related]
14. Neurophysiology and molecular genetics of Charcot-Marie-Tooth type 1 neuropathy in Croatian children: follow-up study.
Barisić N; Mihatov I
Croat Med J; 2000 Sep; 41(3):306-13. PubMed ID: 10962051
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Charcot-Marie-Tooth disease in patients who have bilateral cavovarus feet.
Nagai MK; Chan G; Guille JT; Kumar SJ; Scavina M; Mackenzie WG
J Pediatr Orthop; 2006; 26(4):438-43. PubMed ID: 16791058
[TBL] [Abstract][Full Text] [Related]
16. Neuropathy progression in Charcot-Marie-Tooth disease type 1A.
Shy ME; Chen L; Swan ER; Taube R; Krajewski KM; Herrmann D; Lewis RA; McDermott MP
Neurology; 2008 Jan; 70(5):378-83. PubMed ID: 18227419
[TBL] [Abstract][Full Text] [Related]
17. Charcot-Marie-Tooth disease in Cyprus: epidemiological, clinical and genetic characteristics.
Nicolaou P; Zamba-Papanicolaou E; Koutsou P; Kleopa KA; Georghiou A; Hadjigeorgiou G; Papadimitriou A; Kyriakides T; Christodoulou K
Neuroepidemiology; 2010; 35(3):171-7. PubMed ID: 20571287
[TBL] [Abstract][Full Text] [Related]
18. Charcot-Marie-Tooth disease with intermediate conduction velocities caused by a novel mutation in the MPZ gene.
Banchs I; Casasnovas C; Montero J; Volpini V; Martínez-Matos JA
Muscle Nerve; 2010 Aug; 42(2):184-8. PubMed ID: 20544920
[TBL] [Abstract][Full Text] [Related]
19. Factors that influence health-related quality of life in Australian adults with Charcot-Marie-Tooth disease.
Redmond AC; Burns J; Ouvrier RA
Neuromuscul Disord; 2008 Aug; 18(8):619-25. PubMed ID: 18656353
[TBL] [Abstract][Full Text] [Related]
20. Charcot-Marie-Tooth disease in Denmark: a nationwide register-based study of mortality, prevalence and incidence.
Vaeth S; Vaeth M; Andersen H; Christensen R; Jensen UB
BMJ Open; 2017 Nov; 7(11):e018048. PubMed ID: 29101144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
